Waters Corporation (WAT)

NYSE • Healthcare

$425.21

-$0.31 (-0.1%)

Market closed

Last close at October 2, 2026 at 20:00 UTC

Open$426.78

Day Range$423.44 - $433.34

Avg. Volume (3M)726.4K

Market Cap$41.7B

P/E Ratio105.8

52 Week Range

$282.77$448.21

Next EarningsIn 30 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q3 2026

Revenueeverything earned$1.6B100%

Gross Profitminus cost of goods$734M45%

In plain terms: out of every $100 in revenue, Waters Corporation currently loses $8.

Fundamentals & Financials

Revenue (TTM)

$4.6B

Net Income (TTM)

$166.1M

EPS (TTM)

$4.02

ROA (TTM)

0.67%

Current Ratio

1.86

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+0.3%Q3 2025$2.95

+5.9%Q4 2025$3.4

+0.4%Q1 2026$4.53

+16.9%Q2 2026$2.7

+1.3%Q3 2026$3.05

Nov 3

in 30 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +1.3%

Waters Corporation beat expectations on both the top and bottom line, with preliminary second fiscal quarter of 2026 results reported on August 4, 2026. Revenue rose 113.3% to about $1.65 billion, above the $1.62 billion consensus by 1.4%, as the larger Americas business led the quarter with about $505 million, up 97.3%, while Europe also climbed to roughly $412 million, up 122.7%. Adjusted EPS came in at $3.05, topping the $3.01 estimate by 1.3% and up 3.4% from $2.95 a year ago. Gross profit reached about $734 million, with gross margin near 44.6%, and operating cash flow was $200.0 million. The revenue mix also showed a strong U.S. contribution at about $415 million, up 92.1%. For the next period, consensus calls for adjusted EPS of $3.99 on revenue of $1.75 billion.

View full earnings history

About Waters Corporation

Waters Corporation (NYSE: WAT) makes laboratory instruments and related software for analytical testing and research within the healthcare and diagnostics market, centered on separations, detection, and materials characterization. The company generated $3.2 billion of revenue in FY2025 through instrument, consumables, software, and service offerings used across regulated and research laboratory settings.

Name

Waters Corporation

CEO

Udit Batra

Website

www.waters.com

Industry

Healthcare

Year Founded

1958

Employees

7,900

Today's Snapshot

AI-generated

The day ended with WAT slightly lower at 425.21, in line with a flat sector.

Trading Volume

Below 10d avg (741.3K)

589.6K

vs S&P 500 Today

Underperforming Market

-0.86%

Updated: October 2, 2026 at 20:19 UTC

Technical Indicators

4 Buy3 Neutral1 Sell

WAT shows a constructive technical picture led by a clear trend signal and accumulation. The ADX indicates a firm trend (around 31), and the stock trades well above its 200-day average while sitting just under the short 10-day SMA, reflecting recent consolidation. Momentum is mildly positive even as RSI and MACD read neutral, and OBV is positive, suggesting buying pressure has been sustained. Volatility is moderate, with ATR indicating typical intraday movement rather than extreme swings. Technical takeaway: Buy — trend strength and long-term moving-average support outweigh near-term consolidation.

All signals